Literature DB >> 26350119

Autosomal dominant Parkinson's disease caused by SNCA duplications.

Takuya Konno1, Owen A Ross2, Andreas Puschmann3, Dennis W Dickson4, Zbigniew K Wszolek5.   

Abstract

The discovery in 1997 that mutations in the SNCA gene cause Parkinson's disease (PD) greatly advanced our understanding of this illness. There are pathogenic missense mutations and multiplication mutations in SNCA. Thus, not only a mutant protein, but also an increased dose of wild-type protein can produce autosomal dominant parkinsonism. We review the literature on SNCA duplications and focus on pathologically-confirmed cases. We also report a newly-identified American family with SNCA duplication whose proband was autopsied. We found that over half of the reported cases with SNCA duplication had early-onset parkinsonism and non-motor features, such as dysautonomia, rapid eye movement sleep behavior disorder (RBD), hallucinations (usually visual) and cognitive deficits leading to dementia. Only a few cases have presented with typical features of PD. Our case presented with depression and RBD that preceded parkinsonism, and dysautonomia that led to an initial diagnosis of multiple system atrophy. Dementia and visual hallucinations followed. Our patient and the other reported cases with SNCA duplications had widespread cortical Lewy pathology. Neuronal loss in the hippocampal cornu ammonis 2/3 regions were seen in about half of the autopsied SNCA duplication cases. Similar pathology was also observed in SNCA missense mutation and triplication carriers.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alpha-synuclein; Duplication; Parkinson's disease; Pathology; SNCA

Mesh:

Substances:

Year:  2015        PMID: 26350119      PMCID: PMC4820832          DOI: 10.1016/j.parkreldis.2015.09.007

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  29 in total

1.  Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A.

Authors:  Naoya Aoki; Melissa E Murray; Kotaro Ogaki; Shinsuke Fujioka; Nicola J Rutherford; Rosa Rademakers; Owen A Ross; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2014-11-04       Impact factor: 17.088

2.  Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication.

Authors:  J Fuchs; C Nilsson; J Kachergus; M Munz; E-M Larsson; B Schüle; J W Langston; F A Middleton; O A Ross; M Hulihan; T Gasser; M J Farrer
Journal:  Neurology       Date:  2007-01-24       Impact factor: 9.910

3.  Diversity of pathological features other than Lewy bodies in familial Parkinson's disease due to SNCA mutations.

Authors:  Hiroshige Fujishiro; Akiko Yamashita Imamura; Wen-Lang Lin; Hirotake Uchikado; Margery H Mark; Lawrence I Golbe; Katerina Markopoulou; Zbigniew K Wszolek; Dennis W Dickson
Journal:  Am J Neurodegener Dis       Date:  2013-11-29

4.  Partial trisomy 4q associated with young-onset dopa-responsive parkinsonism.

Authors:  Gaëtan Garraux; Jean-Hubert Caberg; Jean-François Vanbellinghen; Mauricette Jamar; Vincent Bours; Gustave Moonen; Dominique Dive
Journal:  Arch Neurol       Date:  2012-03

5.  Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease.

Authors:  Kenya Nishioka; Shin Hayashi; Matthew J Farrer; Andrew B Singleton; Hiroyo Yoshino; Hisamasa Imai; Toshiaki Kitami; Kenichi Sato; Ryu Kuroda; Hiroyuki Tomiyama; Koichi Mizoguchi; Miho Murata; Tatsushi Toda; Issei Imoto; Johji Inazawa; Yoshikuni Mizuno; Nobutaka Hattori
Journal:  Ann Neurol       Date:  2006-02       Impact factor: 10.422

6.  Re: Alpha-synuclein gene duplication is present in sporadic Parkinson disease.

Authors:  N Brueggemann; P Odin; A Gruenewald; V Tadic; J Hagenah; G Seidel; K Lohmann; C Klein; A Djarmati
Journal:  Neurology       Date:  2008-10-14       Impact factor: 9.910

7.  Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson's disease. Variability in familial Parkinson's disease.

Authors:  K Markopoulou; D W Dickson; R D McComb; Z K Wszolek; L Katechalidou; L Avery; M S Stansbury; B A Chase
Journal:  Acta Neuropathol       Date:  2008-04-04       Impact factor: 17.088

8.  Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia.

Authors:  Takeshi Ikeuchi; Akiyoshi Kakita; Atsushi Shiga; Kensaku Kasuga; Hiryoyuki Kaneko; Chun-Feng Tan; Jiro Idezuka; Koichi Wakabayashi; Osamu Onodera; Takeshi Iwatsubo; Masatoyo Nishizawa; Hitoshi Takahashi; Atsushi Ishikawa
Journal:  Arch Neurol       Date:  2008-04

Review 9.  Update on novel familial forms of Parkinson's disease and multiple system atrophy.

Authors:  Shinsuke Fujioka; Kotaro Ogaki; Pawel M Tacik; Ryan J Uitti; Owen A Ross; Zbigniew K Wszolek
Journal:  Parkinsonism Relat Disord       Date:  2014-01       Impact factor: 4.891

10.  A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants.

Authors:  Manu Sharma; John P A Ioannidis; Jan O Aasly; Grazia Annesi; Alexis Brice; Lars Bertram; Maria Bozi; Maria Barcikowska; David Crosiers; Carl E Clarke; Maurizio F Facheris; Matthew Farrer; Gaetan Garraux; Suzana Gispert; Georg Auburger; Carles Vilariño-Güell; Georgios M Hadjigeorgiou; Andrew A Hicks; Nobutaka Hattori; Beom S Jeon; Zygmunt Jamrozik; Anna Krygowska-Wajs; Suzanne Lesage; Christina M Lill; Juei-Jueng Lin; Timothy Lynch; Peter Lichtner; Anthony E Lang; Cecile Libioulle; Miho Murata; Vincent Mok; Barbara Jasinska-Myga; George D Mellick; Karen E Morrison; Thomas Meitnger; Alexander Zimprich; Grzegorz Opala; Peter P Pramstaller; Irene Pichler; Sung Sup Park; Aldo Quattrone; Ekaterina Rogaeva; Owen A Ross; Leonidas Stefanis; Joanne D Stockton; Wataru Satake; Peter A Silburn; Tim M Strom; Jessie Theuns; Eng-King Tan; Tatsushi Toda; Hiroyuki Tomiyama; Ryan J Uitti; Christine Van Broeckhoven; Karin Wirdefeldt; Zbigniew Wszolek; Georgia Xiromerisiou; Harumi S Yomono; Kuo-Chu Yueh; Yi Zhao; Thomas Gasser; Demetrius Maraganore; Rejko Krüger
Journal:  J Med Genet       Date:  2012-11       Impact factor: 6.318

View more
  60 in total

Review 1.  Clinical Significance of REM Sleep Behavior Disorders and Other Non-motor Symptoms of Parkinsonism.

Authors:  Hong Jin; Jin-Ru Zhang; Yun Shen; Chun-Feng Liu
Journal:  Neurosci Bull       Date:  2017-08-03       Impact factor: 5.203

2.  Multisystem Lewy body disease and the other parkinsonian disorders.

Authors:  J William Langston; Birgitt Schüle; Linda Rees; R Jeremy Nichols; Carrolee Barlow
Journal:  Nat Genet       Date:  2015-12       Impact factor: 38.330

Review 3.  Epigenetic regulation in Parkinson's disease.

Authors:  Catherine Labbé; Oswaldo Lorenzo-Betancor; Owen A Ross
Journal:  Acta Neuropathol       Date:  2016-06-29       Impact factor: 17.088

Review 4.  Genetics of Synucleinopathies.

Authors:  Robert L Nussbaum
Journal:  Cold Spring Harb Perspect Med       Date:  2018-06-01       Impact factor: 6.915

5.  Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment.

Authors:  Richard A Maki; Michael Holzer; Khatereh Motamedchaboki; Ernst Malle; Eliezer Masliah; Gunther Marsche; Wanda F Reynolds
Journal:  Free Radic Biol Med       Date:  2019-06-06       Impact factor: 7.376

Review 6.  Selective neuronal vulnerability in Parkinson disease.

Authors:  D James Surmeier; José A Obeso; Glenda M Halliday
Journal:  Nat Rev Neurosci       Date:  2017-01-20       Impact factor: 34.870

7.  Heterogeneity in α-synuclein fibril activity correlates to disease phenotypes in Lewy body dementia.

Authors:  Arpine Sokratian; Julia Ziaee; Kaela Kelly; Allison Chang; Nicole Bryant; Shijie Wang; Enquan Xu; Joshua Y Li; Shih-Hsiu Wang; John Ervin; Sandip M Swain; Rodger A Liddle; Andrew B West
Journal:  Acta Neuropathol       Date:  2021-02-28       Impact factor: 17.088

Review 8.  Genetics of synucleins in neurodegenerative diseases.

Authors:  José Brás; Elizabeth Gibbons; Rita Guerreiro
Journal:  Acta Neuropathol       Date:  2020-08-01       Impact factor: 17.088

Review 9.  Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature.

Authors:  Susanne A Schneider; Roy N Alcalay
Journal:  Mov Disord       Date:  2017-11       Impact factor: 10.338

Review 10.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.